Atai Life Sciences Investor Relations Material
Latest events
Study Update
Atai Life Sciences
Q2 2025
14 Aug, 2025
Corporate Presentation
2 Jul, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Atai Life Sciences N.V.
Access all reports
Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company focusing on the acquisition, incubation, and development of therapeutics aimed at treating a range of mental health disorders such as depression, anxiety, addiction, among others. The company is developing a decentralized platform approach to expedite the development of effective mental health treatments. The company is headquartered in Berlin, Germany, and its shares are listed on the NASDAQ.
Key slides for Atai Life Sciences N.V.
M&A Announcement
Atai Life Sciences N.V.
Corporate Presentation
Atai Life Sciences N.V.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ATAI
Country
🇺🇸 United States